Metastatic Colorectal Cancers Withdrawn Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Colorectal Cancer Metastatic / Metastatic Colorectal Cancer / Metastatic Colorectal Cancer (MCRC) / Cancer - Metastatic Colorectal / Colorectal Cancer, Metastatic

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03182894Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal CancerTreatment